Here’s a shocking truth: even the most promising careers can be derailed by a single misstep—and for Iasmin Lucindo, that misstep came in the form of a failed drug test. But here’s where it gets controversial: was it intentional doping, or an innocent mistake? The Nevada Athletic Commission (NAC) has just handed down a nine-month suspension to Lucindo, mirroring the exact punishment already imposed by the UFC. This double blow comes after the 24-year-old MMA fighter tested positive for mesterolone, an anabolic steroid, in an out-of-competition sample collected in Brazil. The timing couldn’t be worse—Lucindo was set to face Gillian Robertson at UFC on ESPN 73 on December 13, a fight she’s now been pulled from.
And this is the part most people miss: Lucindo’s case isn’t as cut-and-dried as it seems. According to the CSAD investigation, she didn’t intentionally use mesterolone to gain an edge. Instead, the low-level positive result was traced back to a contaminated supplement. Lucindo even provided documentation from a Brazilian pharmacy showing that mesterolone was regularly compounded into products she used, including legal dietary supplements. So, was she a victim of circumstance, or does responsibility still lie with her? That’s the question sparking debate among fans and experts alike.
The NAC’s decision, announced on Wednesday, includes a $250 fine to cover attorney fees. Lucindo’s suspension will end on June 24, aligning perfectly with the UFC’s timeline. This dual punishment raises eyebrows—is it fair to penalize her twice for the same infraction? Or does it underscore the seriousness of doping violations in combat sports?
Lucindo’s last fight was on August 9, 2025, where she secured a unanimous decision win against Angela Hill. That victory marked her fifth win in six UFC appearances, with her only loss coming against Amanda Lemos. Now, her career is at a standstill, leaving fans to wonder: will she bounce back stronger, or will this setback define her legacy?
Here’s the bold question for you: Should athletes be held accountable for contaminated supplements, or does the responsibility fall on regulatory bodies to ensure product safety? Let’s hear your thoughts in the comments—this is one debate that’s far from over.
